Dr. Laumas has over two decades of experience in healthcare investing across both private and public companies. He has served on boards of directors and held executive roles in publicly traded biotechnology companies, including BioXcel Therapeutics (Nasdaq: BTAI) and Instil Bio, Inc. (Nasdaq: TIL).

Dr. Laumas has served as Chief Financial Officer since February 2021 and as Chief Business Officer since June 2020 at Instil Bio. He began his career at Goldman Sachs & Co. in 1996 in the healthcare investment banking division before transitioning to the healthcare equity research division. He was an analyst at Balyasny Asset Management from 2001 to 2003 and then a Managing Director at North Sound Capital from 2003 to 2007, where he was responsible for the global healthcare investment portfolio.

Since 2008, Dr. Laumas has founded and managed Bearing Circle Capital, an investment partnership. He has also served as a member of the board of directors and Chair of the Audit Committee of BioXcel Therapeutics Inc. since 2017. Previously, he served as a board member of 9 Meters Biopharma, Inc. from 2020 to 2021 and as its Executive Chairman from 2014 to 2020, including serving as Chief Executive Officer from 2019 to 2020.

Dr. Laumas received his A.B. in Chemistry from Cornell University in 1990 and his M.D. from Albany Medical College in 1995, including a research year at the Dana-Farber Cancer Institute. He completed his medical internship at the Yale University School of Medicine in 1996.